Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Marion M. Deken, Marta M. Kijanka, Irati Beltrán Hernández, Maxime D. Slooter, Henriette S. de Bruijn, Paul J. van Diest, Paul M.P. van Bergen en Henegouwen, Clemens W.G.M. Lowik, Dominic J. Robinson, Alexander L. Vahrmeijer, Sabrina Oliveira

Journal title: Journal of Controlled Release

Journal number: 323

Journal publisher: Elsevier BV

Published year: 2020

Published pages: 269-281

DOI identifier: 10.1016/j.jconrel.2020.04.030

ISSN: 0168-3659